RxDoctor Payments Data

Ian Coe, MD

Family Medicine · Reedsport, ORNPI 1902469208

Payments from drug & device makers

$484in general payments, 2019–2025

Across 24 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$98
  • Novartis$90
  • Amgen$83
  • Pfizer$74
  • Lilly USA, LLC$59
  • Exact Sciences$41
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$484 in reported general payments places this provider in the 80th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$2,403
Medicare patients
20
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban74$88,305
JardianceEmpagliflozin52$84,817
EliquisApixaban94$78,607
OzempicSemaglutide70$74,559
TrulicityDulaglutide65$67,977
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$36,252
MounjaroTirzepatide30$31,498
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog47$21,983
EntrestoSacubitril/Valsartan17$17,076
Combivent RespimatIpratropium/Albuterol Sulfate16$15,718
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$13,384
Breo ElliptaFluticasone/Vilanterol24$13,012
Repatha SureclickEvolocumab21$12,540
Advair HfaFluticasone Propion/Salmeterol30$10,586
Albuterol Sulfate HfaAlbuterol Sulfate209$8,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$20$106,65980 claims
Lilly USA, LLCTrulicity, Mounjaro$59$99,47595 claims
PfizerEliquis$74$78,60794 claims
Novo NordiskOzempic$19$74,55970 claims
NovartisEntresto$90$17,07617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Reedsport

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →